Arthur C. Butcher - 02 May 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP& Grp Pres, MedSurg & APAC
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 02 May 2024
Net transactions value: -$73,255
Form type: 4
Filing time: 06 May 2024, 16:17:35 UTC
Previous filing: 14 Mar 2024
Next filing: 29 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+2,102	+7.3%	$0.000000	31,039	02 May 2024	Direct	F1
transaction	BSX	Common Stock	Tax liability	$73,255	-1,017	-3.3%	$72.03	30,022	02 May 2024	Direct
holding	BSX	Common Stock						2,539	02 May 2024	By 401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-2,102	-33%	$0.000000	4,204	02 May 2024	Common Stock	2,102		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.